Sep. 17, 2020—The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).
Sep. 17, 2020—Visionary — someone who thinks about the future or advancements in a creative and imaginative way, a person who is ahead of her or his time and who has a powerful plan for change in the future. Such a person is William “Bill” Stead, MD, Vanderbilt University Medical Center’s Chief Strategy Officer, McKesson Foundation Professor of Biomedical Informatics and Professor of Medicine.
Sep. 17, 2020—Vanderbilt University Medical Center and the University of North Carolina (UNC) at Chapel Hill have been awarded $500,000 by Google’s philanthropy, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to their risk of severe illness and death.
Sep. 17, 2020—When Blair Wheeler banged her elbow on the court floor as she dived for a ball during a high school volleyball game, she had no idea that split second would completely change her life.
Sep. 17, 2020—Donna and Jeffrey Eskind, whose generous gifts have advanced Vanderbilt research that is improving lives, have made a new commitment of $2 million to endow a new chair in autism spectrum disorder research in the School of Medicine.
Sep. 17, 2020—The National Human Genome Research Institute (NHGRI) has awarded a four-year, $4 million grant renewal to Vanderbilt University Medical Center’s Center for Genetic Privacy and Identity in Community Settings (GetPreCiSe).
Sep. 17, 2020—Vanderbilt Heart and Vascular Institute (VHVI) has implanted its first V-Wave, an interatrial shunt device, as a part of a multi-center clinical trial.
Sep. 17, 2020—Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.
Sep. 17, 2020—Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19.